J Clin Transl Hepatol. 2018 Sep 28;6(3):283-288. doi: 10.14218/JCTH.2017.00058. Epub 2018 Apr 5.
Liver Transplantation for Hepatitis B Virus-related Hepatocellular Carcinoma in Hong Kong.Ma KW1, Chok KSH1,2, Fung JYY2,3, Lo CM1,2. Author information1Department of Surgery, The University of Hong Kong, Hong Kong, China.2State Key Laboratory for Liver Research, The University of Hong Kong, Hong Kong, China.3Department of Medicine, The University of Hong Kong, Hong Kong, China.
AbstractHepatocellular carcinoma (HCC) is the fifth most common cancer and the third most common cause of cancer-related deaths worldwide. Curative resection is frequently limited in Hong Kong by hepatitis B virus-related cirrhosis, and liver transplantation is the treatment of choice. Liver transplantation has been shown to produce superior oncological benefits, when compared to hepatectomy for HCC. New developments in the context of patient selection criteria, modification of organ allocation, bridging therapy, salvage liver transplantation and pharmaceutical breakthrough have improved the survival of HCC patients. In this article, we will share our experience in transplanting hepatitis B virus-related HCC patients in Hong Kong and discuss the recent progress in several areas of liver transplantation.